15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering GeneDx Holdings Corp, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $63.00 to $90.00, a moderate spread. The average target of $75.40 sits 22% above the current $61.96. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.10 next quarter toward $1.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to GeneDx Holdings Corp.
As of Jul, 5 of 5 firms rate WGS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
WGS EPS & revenue forecast
EPS · NEXT QUARTER
$0.10
Range $-0.15 – $0.21 · 8 analysts · -79% YoY
Next period, 8 analysts expect GeneDx Holdings Corp. to earn $0.10 a share (range $-0.15 – $0.21), versus $0.49 a year earlier. Full-year consensus is $-0.06, growing to $1.10 the year after.
REVENUE · NEXT QUARTER
$126.1M
Range $124.5M – $131.3M · 8 analysts · +8% YoY
Revenue is expected to reach $126.1M (range $124.5M – $131.3M), +8.0% year-over-year. Full-year consensus is $478.4M, rising to $594.9M next year.
Top analysts covering GeneDx Holdings Corp.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WGS.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #192
Buy
$75.00+21.0% to target
Overall win rate
35%
+ Follow
#2
Matthew Sykes
Goldman Sachs · Rank #226
Hold
$80.00+29.1% to target
Overall win rate
37%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #227
Buy
$63.00+1.7% to target
Overall win rate
31%
+ Follow
#4
Brandon Couillard
Wells Fargo
Buy
$75.00+21.0% to target
Coverage
—
+ Follow
#5
Subbu Nambi
Guggenheim
Buy
$74.00+19.4% to target
Coverage
—
+ Follow
WGS stock forecast FAQ
What is WGS's average 12-month price target?+
The 5 analysts with a live target average $75.40 for GeneDx Holdings Corp. over the next 12 months, ranging from a $90.00 high to a $63.00 low.
Is WGS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for WGS?+
The Street-high target is $90.00 (BTIG), and the Street-low is $63.00 (Piper Sandler). The average of all 5 active targets is $75.40.
How many Wall Street analysts cover WGS?+
5 analysts have an active rating on GeneDx Holdings Corp., and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering WGS?+
Among analysts who currently cover WGS, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #192). Their current call is Buy with a $75.00 target.
What is GeneDx Holdings Corp.'s projected EPS for next quarter?+
The consensus estimate is $0.10 per share (range $-0.15 – $0.21) across 8 analysts. Full-year EPS is projected at $-0.06, rising to $1.10 the following year.
How much revenue is GeneDx Holdings Corp. expected to report next quarter?+
Consensus revenue is $126.1M (range $124.5M – $131.3M). Full-year revenue is projected at $478.4M, growing to $594.9M next year.
Have analysts been upgrading or downgrading WGS lately?+
As of Jul, 5 of 5 firms rate WGS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WGS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
